Pilot study to develop a small molecule activator of TCF4 as a treatment for Pitt-Hopkins syndrome
Awardee: Ben Philpot
Institution: University of North Carolina, Chapel Hill
Award Amount: $51,242
Funding Period: February 1, 2019 - January 31, 2020
Previous
Previous
Tissue-specific and temporal reinstatement of Tcf4 function to treat Pitt-Hopkins Syndrome
Next
Next